Bone biopsy is performed to diagnose various bone disorders such as bone cancer, bone
infection, osteoporosis and chronic kidney disease. Nowadays, biopsy procedure has
received great importance in oncology as one of the promising methods in cancer
diagnostics. The demand for needle biopsy is found to be increasing from last few years.
Increasing prevalence of chronic diseases such as Chronic Kidney Disease (CKD) and
demand new diagnostic services drives the market growth. Additionally, increasing research
and development activities, technological advancements to identify the causes and risk
factors associated with osteopenia and osteoporosis also fuel the market growth of global
market.
The Global Bone Biopsy Market is expected to grow at a CAGR of 5.7% during the forecast
period.
Segmentation:
The Global Bone Biopsy Market is segmented on the basis of type, indication and end user.
On the basis of the component, market is segmented into needle biopsy and open biopsy.
On the basis of the application, the market is segmented into bone cancer, bone infection,
chronic kidney disease, osteoporosis, and others
On the basis of the end user, the market is segmented into hospital & clinics, surgical
centers, diagnostic centers, and others.
Major Players in the Market:
C R Bard (U.S.), Becton, Dickinson and Company (U.S.), B. Braun Melsungen AG, Hologic,
Inc. (U.S.), Cook Medical (U.S.), Devicor Medical Products Inc. (U.S.), Argon Medical Inc.
(U.S.), and others
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5341 .
Regional Analysis:
America is the largest market for bone biopsy owing to the rising prevalence of bone cancer
and osteoporosis along with other bone disorders, extensive use of diagnostic services in
hospitals & surgical centers and increasing importance of early diagnosis of bone cancer. As
per the International Osteoporosis Foundation, over 2 million American men have
osteoporosis. In women, bone loss can begin at as early as 25 years of age. Most of the
American healthcare providers recommend building strong bones before the age of 30, as a
best preventive measure for osteoporosis. Additionally, growing emphasis on healthy
lifestyle and importance of exercise for good health boost the market growth. According to
the Centers for Disease Control and Prevention (2015) in the U.S., 4.9 million adults were
diagnosed with kidney disease. Similarly, according to the U.S. National Kidney Foundation
(2015), more than 660,000 Americans were treated for kidney failure also called end stage
renal disease (ESRD).
Europe is the second largest market owing to the prevalence of osteoporosis, increasing
demand for needle bone biopsy devices and innovative healthcare solutions. Additionally,
changing population demographics is projected to the affect prevalence of osteoporosis in
the European Union (EU).
The market in Asia Pacific is expected to grow rapidly owing to the rising prevalence of
osteoporosis in women after menopause. Moreover, women healthcare is gaining roots in
Asian countries owing rising prevalence of diseases in women such as osteoporosis, obesity,
and diabetes. Japan is the largest market for bone biopsy in Asia Pacific owing to the
flourishing growth of healthcare industry and presence of key players in the market.
The Middle East & Africa also show a steady rise in the market owing to comparatively
lesser demand for bone biopsy than the developed nations and high emphasis on primary
care services. In the Middle East, the market is driven by increasing demand for specialty
care services.
Table of Content for Bone Biopsy Market
Chapter 1. Report Prologue
Chapter 2. Market Introduction